Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (11)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Hamilton-Miller, J. M. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hamilton-Miller, J. M. T.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of Antimicrobial Chemotherapy (1999) 44, 729-734
© 1999 The British Society for Antimicrobial Chemotherapy


Review

ß-Lactams: variations on a chemical theme, with some surprising biological results

J. M. T. Hamilton-Miller*

Department of Medical Microbiology, Royal Free and University College Medical School, London, UK


    Introduction
 
Until the middle of the 1970s virtually all the significant developments in ß-lactam antibiotics had been achieved by adding different side chains to the classical penam and cephem nuclei.1

Notwithstanding the fact that, in earlier decades, manipulation of the penicillin nucleus had failed to produce any novel drugs of interest,2 the second half of the 1970s saw huge progress in useful alterations to the basic penam and cephem ring structures. Penems (Ia) were synthesized,3 naturally occurring carbapenems (Ib, e.g. olivanic acids), oxapenams and monocyclic ß-lactams (nocardicins and monobactams) were discovered,4 ,5 ,6 ,7 and penam sulphones (II) were found to be inhibitors of some ß-lactamases.8 The cephalosporin nucleus was modified to produce microbiologically active oxacephems9 (IIIa) and carbacephems (IIIb).10 Not all changes were advantageous: for example, oxocephems (IV),11 cephams (V)12 and cephems with the double bond in the 2,3 . . . [Full Text of this Article]


    Modifications
 
Antifungal activity

Compounds with a modified ß-lactam ring

Compounds with extra rings

Interactions with g-aminobutyric acid (GABA)

Inhibition of human and viral serine proteases

Inhibition of human cytosolic phospholipase A2

Inhibition of HIV protease

Delivery of anticancer drugs


    Conclusions
 

    Notes
 

    References
 

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Antimicrob. Agents Chemother.Home page
J. M. T. Hamilton-Miller and Q. Li
Enzyme-Catalyzed Antimicrobial Activation
Antimicrob. Agents Chemother., November 1, 2002; 46(11): 3692 - 3692.
[Full Text] [PDF]